Pro-MAGA. Pro-Trump. Pro-America. Pro-Family. Most importantly, Pro-Jesus. Here’s the news aggregator that delivers what America needs right now: jdrucker.com
In this American Greatness article, the author warns that certain state-level crackdowns on pharmacy benefit managers could unintentionally sabotage President Trump’s TrumpRx prescription drug initiative.
- TrumpRx.gov was launched to deliver steep discounts on brand-name medications as part of President Trump’s broader effort to lower prescription drug costs for Americans.
- The program depends heavily on large national pharmacy chains to distribute medications and honor TrumpRx pricing at scale.
- Proposed legislation in states such as Tennessee and Oklahoma would restrict or prohibit PBMs from owning or operating pharmacies.
- If enacted, these laws could force major chains to close or divest locations, limiting where patients can access TrumpRx discounts.
- Independent pharmacies may not have the volume, infrastructure, or negotiating power to match the significant savings negotiated through TrumpRx partnerships.
- The article highlights major price reductions on high-profile drugs to illustrate the real-world impact patients could lose.
- The author argues that well-intentioned state reforms aimed at curbing corporate consolidation could backfire and hurt consumers instead.
- Republicans supporting such measures risk political fallout if voters perceive they are blocking a Trump-backed initiative designed to lower drug prices.
Read the full story: https://amgreatness.com/2026/02/24/a-prescription-for-disaster-saving-trumprx-from-state-legislation/
